Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease.
Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
Myths and misinformation still keep many people in the dark — and that’s bad news for their health.
Phil Greenberg, MD, receives high honor for his contributions to the field.
Advocates, oncologists and researchers share findings, resources and reasons for hope at third annual NW Mets Conference.
The large clinical trial is funded by a $3.5M federal research grant.
Mouse study shows how transplanting patients’ own healthy blood stem cells can curb cancer, opening door to better treatments.
Cancer geneticists, epidemiologists and oncologists team up to use mutation rate to predict individual cancer risk.
How a new technology solved a mystery and honors one man’s legacy
Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer.
A common mutation makes mouse tumors more vulnerable to certain cancer drugs.
Fred Hutch researcher zeroes in on biomarkers to better predict aggressive form of the disease.
The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease.
Author and physician-scientist discusses the next chapters in cancer research—and his book ‘Emperor of all Maladies’—with Hutch presid...
Matthias Stephan, MD, PhD, receives grant to develop cancer vaccine–optimizing, TCR-programming nanotechnology.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.